Folate Therapy and In-Stent Restenosis after Coronary Stenting
Open accessThe DOI matches its Crossref record; 35 of the 36 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Vitamin therapy to lower homocysteine levels has recently been recommended for the prevention of restenosis after coronary angioplasty. We tested the effect of a combination of folic acid, vitamin B6, and vitamin B12 (referred to as folate therapy) on the risk of angiographic restenosis after coronary-stent placement in a double-blind, multicenter trial. METHODS: A total of 636 patients who had undergone successful coronary stenting were randomly assigned to receive 1 mg of folic acid, 5 mg of vitamin B6, and 1 mg of vitamin B12 intravenously, followed by daily oral doses of 1.2 mg of folic acid, 48 mg of vitamin B6, and 60 microg of vitamin B12 for six months, or to receive placebo. The angiographic end points (minimal luminal diameter, late loss, and restenosis rate) were assessed at six months by means of quantitative coronary angiography. RESULTS: At follow-up, the mean (+/-SD) minimal luminal diameter was significantly smaller in the folate group than in the placebo group (1.59+/-0.62 mm vs. 1.74+/-0.64 mm, P=0.008), and the extent of late luminal loss was greater (0.90+/-0.55 mm vs. 0.76+/-0.58 mm, P=0.004). The restenosis rate was higher in the folate group than in the placebo group (34.5 percent vs. 26.5 percent, P=0.05), and a higher percentage of patients in the folate group required repeated target-vessel revascularization (15.8 percent vs. 10.6 percent, P=0.05). Folate therapy had adverse effects on the risk of restenosis in all subgroups except for women, patients with diabetes, and patients with markedly elevated homocysteine levels (15 micromol per liter or more) at baseline. CONCLUSIONS: Contrary to previous findings, the administration of folate, vitamin B6, and vitamin B12 after coronary stenting may increase the risk of in-stent restenosis and the need for target-vessel revascularization.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Trials of homocysteine-reducing vitamin therapy have been disappointing, however.78 -82”
From Diet and Lifestyle Recommendations Revision 2006: A Scientific Statement From the American Heart Association Nutrition Committee (2006) · cites this paper as [81]
Citations
Cites
Morice, M.-C., Serruys, P. W., Sousa, J. E., Fajadet, J., Ban Hayashi, E., Perin, M., Colombo, A., Schuler, G., Barragan, P., Guagliumi, G., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012843 · Cited by 4,033
Homocysteine and Risk of Ischemic Heart Disease and Stroke: A Meta-analysis
Homocysteine Studies Collaboration (2002) · JAMA · doi:10.1001/jama.288.16.2015 · Cited by 2,059
Plasma Homocysteine Levels and Mortality in Patients with Coronary Artery Disease
Nygård, O., Nordrehaug, J. E., Refsum, H., Ueland, P. M., Farstad, M., & Vollset, S. E. (1997) · New England Journal of Medicine · doi:10.1056/nejm199707243370403 · Cited by 1,756
Patterns and Mechanisms of In-Stent Restenosis: A Serial Intravascular Ultrasound Study
Hoffmann, R., Mintz, G. S., Dussaillant, G. R., Popma, J. J., Pichard, A. D., Satler, L. F., Kent, K. M., Griffin, J., & Leon, M. B. (1996) · Circulation · doi:10.1161/01.cir.94.6.1247 · Cited by 1,247
The Effect of Folic Acid Fortification on Plasma Folate and Total Homocysteine Concentrations
Jacques, P. F., Selhub, J., Bostom, A. G., Wilson, P. W. F., & Rosenberg, I. H. (1999) · New England Journal of Medicine · doi:10.1056/nejm199905133401901 · Cited by 1,117
Promotion of vascular smooth muscle cell growth by homocysteine: a link to atherosclerosis.
Tsai, J. C., Perrella, M. A., Yoshizumi, M., Hsieh, C. M., Haber, E., Schlegel, R., & Lee, M. E. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.14.6369 · Cited by 798
Yi, P., Melnyk, S., Pogribna, M., Pogribny, I. P., Hine, R. J., & James, S. J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m002725200 · Cited by 640
Decreased Rate of Coronary Restenosis after Lowering of Plasma Homocysteine Levels
Schnyder, G., Roffi, M., Pin, R., Flammer, Y., Lange, H., Eberli, F. R., Meier, B., Turi, Z. G., & Hess, O. M. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011364 · Cited by 532
Self-citationIngrosso, D., Cimmino, A., Perna, A. F., Masella, L., De Santo, N. G., De Bonis, M. L., Vacca, M., D'Esposito, M., D'Urso, M., Galletti, P., et al. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13372-7 · Cited by 427
Activation of endogenous factor V by a homocysteine-induced vascular endothelial cell activator.
Rodgers, G. M., & Kane, W. H. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112519 · Cited by 384
Research works printed but not linked: 3
- Cook J, 2002, J Vasc Surg, 35, 158
- 10.1097/00043798-200102000-00002 · doi:10.1097/00043798-200102000-00002
- Benoit C, 1999, Arch Mal Coeur Vaiss, 92, 1457
Cited by
Lichtenstein, A. H., Appel, L. J., Brands, M., Carnethon, M., Daniels, S., Franch, H. A., Franklin, B., Kris-Etherton, P., Harris, W. S., Howard, B., et al. (2006) · Circulation · doi:10.1161/circulationaha.106.176158 · Cited by 2,705
Homocysteine Lowering and Cardiovascular Events after Acute Myocardial Infarction
Bønaa, K. H., Njølstad, I., Ueland, P. M., Schirmer, H., Tverdal, A., Steigen, T., Wang, H., Nordrehaug, J. E., Arnesen, E., & Rasmussen, K. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa055227 · Cited by 1,442
Evidence-Based Guidelines for Cardiovascular Disease Prevention in Women: 2007 Update
Mosca, L., Banka, C. L., Benjamin, E. J., Berra, K., Bushnell, C., Dolor, R. J., Ganiats, T. G., Gomes, A. S., Gornik, H. L., Gracia, C., et al. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.02.020 · Cited by 757
Is folic acid good for everyone?
Smith, A. D., Kim, Y.-I., & Refsum, H. (2008) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/87.3.517 · Cited by 612
Efficacy of folic acid supplementation in stroke prevention: a meta-analysis
Wang, X., Qin, X., Demirtas, H., Li, J., Mao, G., Huo, Y., Sun, N., Liu, L., & Xu, X. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60854-x · Cited by 589
Evidence-Based Guidelines for Cardiovascular Disease Prevention in Women: 2007 Update
Mosca, L., Banka, C. L., Benjamin, E. J., Berra, K., Bushnell, C., Dolor, R. J., Ganiats, T. G., Gomes, A. S., Gornik, H. L., Gracia, C., et al. (2007) · Circulation · doi:10.1161/circulationaha.107.181546 · Cited by 579
Homocysteine lowering interventions for preventing cardiovascular events
Martí-Carvajal, A. J., Solà, I., Lathyris, D., & Salanti, G. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006612.pub2 · Cited by 520
Albert, C. M., Cook, N. R., Gaziano, J. M., Zaharris, E., MacFadyen, J., Danielson, E., Buring, J. E., & Manson, J. E. (2008) · JAMA · doi:10.1001/jama.299.17.2027 · Cited by 511
Refsum, H., Nurk, E., David Smith, A., Ueland, P. M., Gjesdal, C. G., Bjelland, I., Tverdal, A., Tell, G. S., Nygård, O., & Vollset, S. E. (2006) · The Journal of Nutrition · doi:10.1093/jn/136.6.1731s · Cited by 493
Myung, S.-K., Ju, W., Cho, B., Oh, S.-W., Park, S. M., Koo, B.-K., Park, B.-J., & for the Korean Meta-Analysis (KORMA) Study Group (2013) · BMJ · doi:10.1136/bmj.f10 · Cited by 467
Galan, P., Kesse-Guyot, E., Czernichow, S., Briancon, S., Blacher, J., Hercberg, S., & for the SU.FOL.OM3 Collaborative Group (2010) · BMJ · doi:10.1136/bmj.c6273 · Cited by 457
Bazzano, L. A., Reynolds, K., Holder, K. N., & He, J. (2006) · JAMA · doi:10.1001/jama.296.22.2720 · Cited by 426
Ebbing, M., Bleie, Ø., Ueland, P. M., Nordrehaug, J. E., Nilsen, D. W., Vollset, S. E., Refsum, H., Ringdal Pedersen, E. K., & Nygård, O. (2008) · JAMA · doi:10.1001/jama.300.7.795 · Cited by 411
Antoniades, C., Shirodaria, C., Warrick, N., Cai, S., de Bono, J., Lee, J., Leeson, P., Neubauer, S., Ratnatunga, C., Pillai, R., et al. (2006) · Circulation · doi:10.1161/circulationaha.106.612325 · Cited by 365
Mechanisms of homocysteine‐induced atherothrombosis
LENTZ, S. R. (2005) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2005.01364.x · Cited by 363
Micronutrients in Health and Disease
Shenkin, A. (2006) · Postgraduate Medical Journal · doi:10.1136/pgmj.2006.047670 · Cited by 357
Summary of American Heart Association Diet and Lifestyle Recommendations Revision 2006
Lichtenstein, A. H., Appel, L. J., Brands, M., Carnethon, M., Daniels, S., Franch, H. A., Franklin, B., Kris-Etherton, P., Harris, W. S., Howard, B., et al. (2006) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000238352.25222.5e · Cited by 345
Folic acid: a public-health challenge
Eichholzer, M., Tönz, O., & Zimmermann, R. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68582-6 · Cited by 325
The Treatment of Hyperhomocysteinemia
Maron, B. A., & Loscalzo, J. (2009) · Annual Review of Medicine · doi:10.1146/annurev.med.60.041807.123308 · Cited by 313
Homocysteine Trials — Clear Outcomes for Complex Reasons
Loscalzo, J. (2006) · New England Journal of Medicine · doi:10.1056/nejme068060 · Cited by 300
Homocysteine and cardiovascular disease: a review of the evidence
Wierzbicki, A. S. (2007) · Diabetes and Vascular Disease Research · doi:10.3132/dvdr.2007.033 · Cited by 287
Coronary Stent Restenosis in Patients Treated With Cilostazol
Douglas, J. S., Holmes, D. R., Kereiakes, D. J., Grines, C. L., Block, E., Ghazzal, Z. M. B., Morris, D. C., Liberman, H., Parker, K., Jurkovitz, C., et al. (2005) · Circulation · doi:10.1161/circulationaha.104.530097 · Cited by 281
Homocysteine-lowering interventions for preventing cardiovascular events
Martí-Carvajal, A. J., Solà, I., Lathyris, D., & Dayer, M. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006612.pub5 · Cited by 275
Li, Y., Huang, T., Zheng, Y., Muka, T., Troup, J., & Hu, F. B. (2016) · Journal of the American Heart Association · doi:10.1161/jaha.116.003768 · Cited by 265
Homocysteine and coronary atherosclerosis: from folate fortification to the recent clinical trials
Antoniades, C., Antonopoulos, A. S., Tousoulis, D., Marinou, K., & Stefanadis, C. (2008) · European Heart Journal · doi:10.1093/eurheartj/ehn515 · Cited by 259
Vitamin Intervention for Stroke Prevention Trial: An Efficacy Analysis
Spence, J. D., Bang, H., Chambless, L. E., & Stampfer, M. J. (2005) · Stroke · doi:10.1161/01.str.0000185929.38534.f3 · Cited by 244
Zoungas, S., McGrath, B. P., Branley, P., Kerr, P. G., Muske, C., Wolfe, R., Atkins, R. C., Nicholls, K., Fraenkel, M., Hutchison, B. G., et al. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.10.064 · Cited by 241
Homocysteine-lowering therapy: a role in stroke prevention?
Spence, J. D. (2007) · The Lancet Neurology · doi:10.1016/s1474-4422(07)70219-3 · Cited by 220
Wald, D. S., Wald, N. J., Morris, J. K., & Law, M. (2006) · BMJ · doi:10.1136/bmj.39000.486701.68 · Cited by 218
CVD risk factors and ethnicity—A homogeneous relationship?
Forouhi, N. G., & Sattar, N. (2006) · Atherosclerosis Supplements · doi:10.1016/j.atherosclerosissup.2006.01.003 · Cited by 215
The Many Facets of Hyperhomocysteinemia: Studies from the Framingham Cohorts
Selhub, J. (2006) · The Journal of Nutrition · doi:10.1093/jn/136.6.1726s · Cited by 212
The key role of micronutrients☆
SHENKIN, A. (2006) · Clinical Nutrition · doi:10.1016/j.clnu.2005.11.006 · Cited by 208
Mitofusin 2 Triggers Vascular Smooth Muscle Cell Apoptosis via Mitochondrial Death Pathway
Guo, X., Chen, K.-H., Guo, Y., Liao, H., Tang, J., & Xiao, R.-P. (2007) · Circulation Research · doi:10.1161/circresaha.107.157644 · Cited by 200
Homocysteine and thrombosis: from basic science to clinical evidence
Brożek, J., Szczeklik, A., & Undas, A. (2005) · Thrombosis and Haemostasis · doi:10.1160/th05-05-0313 · Cited by 197
Wright, A. J. A., Dainty, J. R., & Finglas, P. M. (2007) · British Journal of Nutrition · doi:10.1017/s0007114507777140 · Cited by 186
Christen, W. G., Glynn, R. J., Chew, E. Y., Albert, C. M., & Manson, J. E. (2009) · Archives of Internal Medicine · doi:10.1001/archinternmed.2008.574 · Cited by 180
Homocysteine Hypothesis for Atherothrombotic Cardiovascular Disease
Kaul, S., Zadeh, A. A., & Shah, P. K. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.04.086 · Cited by 176
Bleys, J., Miller, E. R., Pastor-Barriuso, R., Appel, L. J., & Guallar, E. (2006) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/84.4.880 · Cited by 174
Hyperhomocysteinemia and Thrombosis: An Overview
Eldibany, M. M., & Caprini, J. A. (2007) · Archives of Pathology & Laboratory Medicine · doi:10.5858/2007-131-872-hatao · Cited by 171
Mood disorders and complementary and alternative medicine: a literature review
Qureshi, N. A., & Al-Bedah (2013) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s43419 · Cited by 155
Efficacy of Homocysteine-Lowering Therapy With Folic Acid in Stroke Prevention: A Meta-Analysis
Lee, M., Hong, K.-S., Chang, S.-C., & Saver, J. L. (2010) · Stroke · doi:10.1161/strokeaha.109.573410 · Cited by 154
Pathogenesis of Atherosclerosis
Crowther, M. A. (2005) · Hematology · doi:10.1182/asheducation-2005.1.436 · Cited by 156
Integrating Complementary Medicine Into Cardiovascular Medicine
Vogel, J. H. K., Bolling, S. F., Costello, R. B., Guarneri, E. M., Krucoff, M. W., Longhurst, J. C., Olshansky, B., Pelletier, K. R., Tracy, C. M., Vogel, R. A., et al. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.05.031 · Cited by 159
Dalmeijer, G. W., Olthof, M. R., Verhoef, P., Bots, M. L., & van der Schouw, Y. T. (2008) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1602725 · Cited by 131
Subgroup analyses in therapeutic cardiovascular clinical trials: Are most of them misleading?
Hernández, A. V., Boersma, E., Murray, G. D., Habbema, J. D. F., & Steyerberg, E. W. (2006) · American Heart Journal · doi:10.1016/j.ahj.2005.04.020 · Cited by 131
Cardiovascular and thrombophilic risk factors for idiopathic sudden sensorineural hearing loss
Marcucci, R., Liotta, A. A., Cellai, A. P., Rogolino, A. A., Berloco, P. B., Leprini, E., Pagnini, P., Abbate, R., & Prisco, D. (2005) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2005.01310.x · Cited by 128
Essential Nutrients: Food or Supplements?: Where Should the Emphasis Be?
Lichtenstein, A. H., & Russell, R. M. (2005) · JAMA · doi:10.1001/jama.294.3.351 · Cited by 125
Huang, T., Chen, Y., Yang, B., Yang, J., Wahlqvist, M. L., & Li, D. (2012) · Clinical Nutrition · doi:10.1016/j.clnu.2011.01.003 · Cited by 135
Homocysteine as a risk factor for cardiovascular disease: should we (still) worry about?
Faeh, D., Chioléro, A., & Paccaud, F. (2006) · Swiss Medical Weekly · doi:10.4414/smw.2006.11283 · Cited by 166
A trial of B vitamins and cognitive function among women at high risk of cardiovascular disease
Kang, J. H., Cook, N., Manson, J., Buring, J. E., Albert, C. M., & Grodstein, F. (2008) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.2008.26404 · Cited by 114
Homocysteine-lowering interventions for preventing cardiovascular events
Martí-Carvajal, A. J., Solà, I., & Lathyris, D. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006612.pub4 · Cited by 113
Miller, E. R., Juraschek, S., Pastor-Barriuso, R., Bazzano, L. A., Appel, L. J., & Guallar, E. (2010) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2010.03.064 · Cited by 112
Vitamin B6: a challenging link between nutrition and inflammation in CVD
Lotto, V., Choi, S.-W., & Friso, S. (2011) · British Journal of Nutrition · doi:10.1017/s0007114511000407 · Cited by 111
Schaffer, A., Verdoia, M., Cassetti, E., Marino, P. N., Suryapranata, H., & Luca, G. D. (2014) · Thrombosis Research · doi:10.1016/j.thromres.2014.05.025 · Cited by 114
Self-citationYang, H.-T., Lee, M., Hong, K., Ovbiagele, B. I., & Saver, J. L. (2012) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2012.07.004 · Cited by 117
Mechanisms and potential therapeutic targets for folic acid in cardiovascular disease
Moens, A. L., Vrints, C. J., Claeys, M. J., Timmermans, J.-P., Champion, H. C., & Kass, D. A. (2008) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.91503.2007 · Cited by 105
Homocysteine: is it a clinically important cardiovascular risk factor?
Lentz, S. R., & Haynes, W. G. (2004) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.71.9.729 · Cited by 118
Nutrition and Stroke Prevention
Fisher, M., Lees, K. R., & Spence, J. D. (2006) · Stroke · doi:10.1161/01.str.0000236633.40160.ee · Cited by 112
Hung, K.-C., Wu, C.-C., Chen, H.-S., Ma, W.-Y., Tseng, C.-F., Yang, L.-K., Hsieh, H.-L., & Lu, K.-C. (2011) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfq411 · Cited by 94
Cacciapuoti, F. (2011) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-011-0550-4 · Cited by 108
Efficacy of folic acid supplementation in stroke prevention: new insight from a meta-analysis
Huo, Y., Qin, X., Wang, J., Sun, N., Zeng, Q., Xu, X., Liu, L., Xu, X., & Wang, X. (2012) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2012.02929.x · Cited by 93
Hajer, G. R., van der Graaf, Y., Olijhoek, J. K., Verhaar, M. C., Visseren, F. L. J., & for the SMART Study Group (2005) · Heart · doi:10.1136/hrt.2006.093971 · Cited by 94
Homocysteine-lowering interventions for preventing cardiovascular events
Martí-Carvajal, A. J., Solà, I., Lathyris, D., Karakitsiou, D.-E., & Simancas‐Racines, D. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006612.pub3 · Cited by 108
Folic acid in general medicine and dermatology
Gisondi, P., Fantuzzi, F., Malerba, M., & Girolomoni, G. (2007) · Journal of Dermatological Treatment · doi:10.1080/09546630701247930 · Cited by 92
Abraham, J. M., & Cho, L. (2010) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.77a.10036 · Cited by 93
Zhou, Y.-H., Tang, J.-Y., Wu, M.-J., Lu, J., Wei, X., Qin, Y.-Y., Wang, C., Xu, J.-F., & He, J. (2011) · PLoS ONE · doi:10.1371/journal.pone.0025142 · Cited by 83
Homocysteine and arterial thrombosis: Challenge and opportunity
Tremoli, E., Coppola, A., Lupoli, R., Minno, G. D., & Minno, M. N. D. D. (2010) · Thrombosis and Haemostasis · doi:10.1160/th09-06-0393 · Cited by 85
Chang, P., Lu, S., Lee, C., Chen, Y.-J., Dugan, T. A., Huang, W.-H., Chang, S., Liao, W. S. ‐., Chen, C., & Lee, Y. (2008) · Circulation Research · doi:10.1161/circresaha.108.171082 · Cited by 87
The Year in Interventional Cardiology
Dixon, S. R., Grines, C. L., & O’Neill, W. W. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.02.021 · Cited by 78
Robertson, J., Iemolo, F., Stabler, S. P., Allen, R. H., & Spence, J. D. (2005) · Canadian Medical Association Journal · doi:10.1503/cmaj.045055 · Cited by 82
Methoxistasis: Integrating the Roles of Homocysteine and Folic Acid in Cardiovascular Pathobiology
Joseph, J., & Loscalzo, J. (2013) · Nutrients · doi:10.3390/nu5083235 · Cited by 79
Homocysteine and Glutathione Peroxidase-1
Lubos, E., Loscalzo, J., & Handy, D. E. (2007) · Antioxidants and Redox Signaling · doi:10.1089/ars.2007.1771 · Cited by 75
Gender differences in homocysteine concentrations, a population-based cross-sectional study
Cohen, E., Margalit, I., Shochat, T., Goldberg, E., & Krause, I. (2018) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2018.09.003 · Cited by 85
Zeng, R., Xu, C.-H., Xu, Y., Wang, Y., & Wang, M. (2014) · Public Health Nutrition · doi:10.1017/s1368980014002134 · Cited by 81
Potter, K., Hankey, G. J., Green, D. J., Eikelboom, J., Jamrozik, K., & Arnolda, L. F. (2008) · BMC Cardiovascular Disorders · doi:10.1186/1471-2261-8-24 · Cited by 70
The controversial role of B-vitamins in cardiovascular risk: An update
Ntaios, G., Savopoulos, C. G., Grekas, D. M., & Hatzitolios, A. I. (2009) · Archives of cardiovascular diseases · doi:10.1016/j.acvd.2009.07.002 · Cited by 80
Zee, R. Y. L., Mora, S., Cheng, S., Erlich, H. A., Lindpaintner, K., Rifai, N., Buring, J. E., & Ridker, P. M. (2007) · Clinical Chemistry · doi:10.1373/clinchem.2006.083881 · Cited by 78
Guéant, J., Guéant‐Rodriguez, R., Oussalah, A., Zuily, S., & Rosenberg, I. H. (2022) · Thrombosis and Haemostasis · doi:10.1055/a-1952-1946 · Cited by 80
Safety Considerations and Potential Interactions of Vitamins: Should Vitamins Be Considered Drugs?
Rogovik, A. L., Vohra, S., & Goldman, R. D. (2009) · Annals of Pharmacotherapy · doi:10.1345/aph.1m238 · Cited by 73
Hankey, G. J., & Eikelboom, J. W. (2005) · The Lancet · doi:10.1016/s0140-6736(05)17751-4 · Cited by 73
Secondary prevention with folic acid: results of the Goes extension study: Figure 1
Liem, A., Reynierse-Buitenwerf, G. H., Zwinderman, A. H., Jukema, J. W., & van Veldhuisen, D. J. (2005) · Heart · doi:10.1136/hrt.2004.035030 · Cited by 64
Effect of Lowering of Homocysteine Levels on Inflammatory Markers: A Randomized Controlled Trial
Durga, J., van Tits, L. J. H., Schouten, E. G., Kok, F. J., & Verhoef, P. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.12.1388 · Cited by 63
Folate supplementation and cardiovascular disease
Smith, G. D., & Ebrahim, S. B. J. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67676-3 · Cited by 66
Ishihara, J., Iso, H., Inoue, M., Iwasaki, M., Okada, K., Kita, Y., Kokubo, Y., Okayama, A., Tsugane, S., & for the JPHC Study Group (2008) · Journal of the American College of Nutrition · doi:10.1080/07315724.2008.10719684 · Cited by 69
Metabolism of Homocysteine and its Relationship with Cardiovascular Disease
Aguilar, B., Rojas, J. C., & Collados, M. T. (2004) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-004-0204-x · Cited by 61
Güallar, E., Silbergeld, E. K., Navas‐Acién, A., Malhotra, S., Astor, B. C., Sharrett, A. R., & Schwartz, B. S. (2006) · American Journal of Epidemiology · doi:10.1093/aje/kwj090 · Cited by 64
Folic acid supplements and colorectal cancer risk: meta-analysis of randomized controlled trials
Qin, T., Du, M., Du, H., Shu, Y., Wang, M., & Zhu, L. (2015) · Scientific Reports · doi:10.1038/srep12044 · Cited by 68
Mei, W., Rong, Y., Jinming, L., Yongjun, L., & Hui, Z. (2009) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2009.02207.x · Cited by 59
Cobalamin deficiency, hyperhomocysteinemia, and dementia
Werder (2010) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s6564 · Cited by 65
Bleie, Ø., Semb, A. G., Grundt, H., Nordrehaug, J. E., Vollset, S. E., Ueland, P. M., Nilsen, D. W. T., Bakken, A. M., Refsum, H., & Nygård, O. K. (2007) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2007.01810.x · Cited by 57
Lonn, E., Held, C., Arnold, J. M. O., Probstfield, J., McQueen, M., Micks, M., Pogue, J., Sheridan, P., Bosch, J., Genest, J., et al. (2006) · Canadian Journal of Cardiology · doi:10.1016/s0828-282x(06)70238-0 · Cited by 65
Clinical usefulness of plasma homocysteine in vascular disease
Hankey, G. J., Eikelboom, J. W., Ho, W. K., & BOCKXMEER, F. M. V. (2004) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.2004.tb06296.x · Cited by 60
Quo Vadis: Whither Homocysteine Research?
Joseph, J., Handy, D. E., & Loscalzo, J. (2009) · Cardiovascular Toxicology · doi:10.1007/s12012-009-9042-6 · Cited by 56
Meta-analysis of folic acid efficacy trials in stroke prevention: Insight into effect modifiers
Zhao, M., Wu, G., Li, Y., Wang, X., Hou, F. F., Xu, X., Qin, X., & Cai, Y. (2017) · Neurology · doi:10.1212/wnl.0000000000003909 · Cited by 57
Marcucci, R., Brogi, D., Sofi, F., Giglioli, C., Valente, S., Liotta, A. A., Lenti, M., Gori, A. M., Prisco, D., Abbate, R., et al. (2005) · Heart · doi:10.1136/hrt.2005.061895 · Cited by 54
The year in interventional cardiology
O’Neill, W. W., Dixon, S. R., & Grines, C. L. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.01.006 · Cited by 49
A comparative study of restenosis rates in bare metal and drug-eluting stents
Mohan, S. C., & Dhall, A. (2010) · International Journal of Angiology · doi:10.1055/s-0031-1278368 · Cited by 48
Løland, K. H., Bleie, Ø., Blix, A. J., Strand, E., Ueland, P. M., Refsum, H., Ebbing, M., Nordrehaug, J. E., & Nygard, O. K. (2010) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2010.01.019 · Cited by 48
Rader, J. I., & Schneeman, B. O. (2006) · PEDIATRICS · doi:10.1542/peds.2005-2745 · Cited by 54
Wang, Y., Yang, J., Wang, Y., Li, L., Liao, Y., Zhang, Y., & Yu, D. S. (2019) · Medicine · doi:10.1097/md.0000000000017095 · Cited by 57
Metadata
- Authors
- Lange, H., Suryapranata, H., De Luca, G., Börner, C., Dille, J., Kallmayer, K., Pasalary, M. N., Scherer, E., & Dambrink, J.-H. E.
- Affiliations
- Klinikum Links der Weser (DE)
- Isala (NL)
- Diagram (Netherlands) (NL)
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2004-06-24
- Volume
- 350
- Issue
- 26
- Pages
- 2673-2681
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W1968517325
- Cited by
- 336
- References
- 36
- Citations by year
- 2026: 1 · 2025: 5 · 2024: 2 · 2023: 2 · 2022: 3 · 2021: 3 · 2020: 6 · 2019: 4 · 2018: 1 · 2017: 3 · 2016: 5 · 2015: 8 · 2014: 13 · 2013: 14 · 2012: 12
- FWCI
- 34.22
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Nursing › Nutrition and Dietetics › Folate and B Vitamins Research
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Coronary Interventions and Diagnostics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Acute Myocardial Infarction Research
- Keywords
- folate therapy, in-stent restenosis, coronary stenting, vitamin B6, vitamin B12, folic acid, homocysteine, late lumen loss, target vessel revascularization, coronary angioplasty, vitamin supplementation
- MeSH terms
- Aged, Coronary Disease, Coronary Vessels, Double-Blind Method, Drug Therapy, Combination, Female, Folic Acid, Homocysteine, Humans, Male, Middle Aged, Risk Factors, Vitamin B 12, Stents, Coronary Angiography, Treatment Failure, Hyperhomocysteinemia, Coronary Restenosis, Vitamin B 6
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.